Skip to main content
Eli Lilly and Company (ETR:LLY)
Germany flag Germany · Delayed Price · Currency is EUR
870.50
+3.10 (0.36%)
At close: Dec 5, 2025

Eli Lilly and Company Revenue

Eli Lilly and Company had revenue of $17.60B USD in the quarter ending September 30, 2025, with 53.87% growth. This brings the company's revenue in the last twelve months to $59.42B, up 45.41% year-over-year. In the year 2024, Eli Lilly and Company had annual revenue of $45.04B with 32.00% growth.

Revenue (ttm)
$59.42B
Revenue Growth
+45.41%
P/S Ratio
15.35
Revenue / Employee
$1.26M
Employees
47,000
Market Cap
777.61B EUR

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202445.04B10.92B32.00%
Dec 31, 202334.12B5.58B19.56%
Dec 31, 202228.54B223.00M0.79%
Dec 31, 202128.32B3.78B15.40%
Dec 31, 202024.54B2.22B9.95%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Merck KGaA 21.27B
Siemens Healthineers AG 23.38B
Bayer Aktiengesellschaft 45.87B
Fresenius SE & Co. KGaA 22.45B
Sartorius Aktiengesellschaft 3.52B
Fresenius Medical Care AG 19.64B
Carl Zeiss Meditec AG 2.18B
Fielmann Group AG 2.42B
Revenue Rankings

Eli Lilly and Company News

More News